Table 1 Clinical features in 98 DLBCL Brazilian patients

Male, n (%)

49 (50.0)

Age, median (IQR)

54.5 (46.2–66.7)

BM+, n (%)

13 (13.3)

CNS+, n (%)

2 (2.0)

Extranodal sites ≥2, n (%) ^a

7 (7.1)

ECOG > 2, n (%) ^b

50 (50.0)

Bulky disease, n (%) ^b

44 (44.9)

B symptoms, n (%) ^a

66 (67.3)

 I

10 (10.2)

 II

30 (30.6)

 III

13 (13.2)

 IV

41 (41.8)

 Low risk

24 (24.5)

 Low-intermediate

20 (20.4)

 Intermediate-high

22 (22.4)

 High risk

27 (27.5)